WJ, J., EJ, J., YJ, K., M, P., E, K., YS, J., . . . N, J. (2026). Characteristics of Immune Checkpoint Inhibitor-Related Hepatotoxicity Based on the Baseline Liver Function. Cancer research and treatment, 58(3), 709. https://doi.org/10.4143/crt.2025.040
Chicago Style (17th ed.) CitationWJ, Jung, et al. "Characteristics of Immune Checkpoint Inhibitor-Related Hepatotoxicity Based on the Baseline Liver Function." Cancer Research and Treatment 58, no. 3 (2026): 709. https://doi.org/10.4143/crt.2025.040.
MLA (9th ed.) CitationWJ, Jung, et al. "Characteristics of Immune Checkpoint Inhibitor-Related Hepatotoxicity Based on the Baseline Liver Function." Cancer Research and Treatment, vol. 58, no. 3, 2026, p. 709, https://doi.org/10.4143/crt.2025.040.
Warning: These citations may not always be 100% accurate.
